Comparison of SARS-CoV-2 variants in primary human nasal cultures indicates Delta as most cytopathic and Omicron as fastest replicating

The ongoing SARS-CoV-2 pandemic has been marked with emerging viral variants, some of which were designated as variants of concern (VOCs) due to their selection and rapid circulation in the human population. Here we elucidate functional features of each VOC linked to variations in growth during infection. Patient-derived primary nasal cultures grown at air-liquid-interface (ALI) were used to model upper-respiratory infection, and human lung epithelial cell lines used to model lower-respiratory infection. All VOCs replicated to higher titers than the ancestral virus, suggesting a selection for replication efficiency. In primary nasal ALI cultures, Omicron replicated to the highest titers at early time points, followed by Delta, paralleling comparative studies of patient samples. All SARS-CoV-2 viruses entered the cell primarily via a transmembrane serine protease 2 (TMPRSS2)-dependent pathway, and Omicron was more likely to use an endosomal route of entry. All VOCs overcame dsRNA-activated cellular responses including interferon signaling, oligoadenylate ribonuclease L (OAS-RNase L) degradation and protein kinase R (PKR) activation. Infections in nasal ALI resulted in damage to nasal cells such as a compromise of cell-barrier integrity and loss of nasal cilia and ciliary beating function, especially with Delta infections. Overall, Omicron replication was optimized for growth in the upper-respiratory system and least-favorable in the lower-respiratory cell line; and Delta was the most cytopathic for both upper and lower respiratory cells. Our findings highlight the functional differences among VOCs and illuminate distinct mechanisms of pathogenesis in infected individuals. Significance Statement In a comparative analysis of infections by SARS-CoV-2 ancestral virus and variants of concern including Alpha, Beta, Delta and Omicron, we found that variants are selected for efficiency in replication. In infections of patient-derived primary nasal cultures grown at air-liquid-interface (ALI) to model upper-respiratory infection, we show that Omicron reached highest titers at early time points, a finding that is confirmed by parallel studies of patient sampling. In both primary nasal cells and lower-respiratory cell lines infections by Delta are most damaging to the cells as indicated by syncytia formation and loss of nasal ciliary function.

[1]  Jyoti R. Yemul,et al.  Comparative pathogenicity of BA.2.12, BA.5.2 and XBB.1 with the Delta variant in Syrian hamsters , 2023, Frontiers in microbiology.

[2]  Sean J. Humphrey,et al.  Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment , 2023, Stem cell reports.

[3]  N. Cohen,et al.  Infection of primary nasal epithelial cells differentiates among lethal and seasonal human coronaviruses , 2023, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Mokhtari-azad,et al.  The reproduction rate of severe acute respiratory syndrome coronavirus 2 different variants recently circulated in human: a narrative review , 2023, European Journal of Medical Research.

[5]  William T. Harvey,et al.  SARS-CoV-2 variant biology: immune escape, transmission and fitness , 2023, Nature Reviews Microbiology.

[6]  A. Awasthi,et al.  Intrinsic D614G and P681R/H mutations in SARS-CoV-2 VoCs Alpha, Delta, Omicron and viruses with D614G plus key signature mutations in spike protein alters fusogenicity and infectivity , 2022, Medical Microbiology and Immunology.

[7]  Wassan Nori,et al.  Omicron targets upper airways in pediatrics, elderly and unvaccinated population , 2022, World journal of clinical cases.

[8]  S. Vashee,et al.  A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8 , 2022, bioRxiv.

[9]  S. Subramaniam,et al.  SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization , 2022, Nature Communications.

[10]  Christian J. H. von Wintersdorff,et al.  Infections with the SARS-CoV-2 Delta variant exhibit fourfold increased viral loads in the upper airways compared to Alpha or non-variants of concern , 2022, Scientific Reports.

[11]  William T. Harvey,et al.  SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway , 2022, Nature Microbiology.

[12]  W. Baumgärtner,et al.  SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters , 2022, Nature Communications.

[13]  T. Blundell,et al.  In silico analysis of mutations near S1/S2 cleavage site in SARS‐CoV‐2 spike protein reveals increased propensity of glycosylation in Omicron strain , 2022, Journal of medical virology.

[14]  Arvind H. Patel,et al.  The altered entry pathway and antigenic distance of the SARS-CoV-2 Omicron variant map to separate domains of spike protein , 2022, bioRxiv.

[15]  E. Klein,et al.  The displacement of the SARS-CoV-2 variant Delta with Omicron: An investigation of hospital admissions and upper respiratory viral loads , 2022, eBioMedicine.

[16]  A. Huppert,et al.  Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection , 2022, Nature Communications.

[17]  D. Dean,et al.  SARS-CoV-2 variants of concern Alpha and Delta show increased viral load in saliva , 2022, medRxiv.

[18]  M. Diamond,et al.  Innate immunity: the first line of defense against SARS-CoV-2 , 2022, Nature Immunology.

[19]  Frances E. Muldoon,et al.  Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.

[20]  M. Wass,et al.  Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates , 2022, Cell Research.

[21]  D. Purcell,et al.  Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection , 2022, International journal of molecular sciences.

[22]  Vineet D. Menachery,et al.  QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis , 2021, bioRxiv.

[23]  Brendan J. Kelly,et al.  SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021 , 2021, medRxiv.

[24]  E. Frolova,et al.  Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve In Vitro to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage , 2021, Journal of virology.

[25]  Vineet D. Menachery,et al.  Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2021, bioRxiv.

[26]  G. Whittaker SARS-CoV-2 spike and its adaptable furin cleavage site , 2021, The Lancet Microbe.

[27]  D. Meyerholz,et al.  The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19 , 2021, mBio.

[28]  O. Pybus,et al.  Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool , 2021, Virus evolution.

[29]  S. Boulant,et al.  TMPRSS2 expression dictates the entry route used by SARS‐CoV‐2 to infect host cells , 2021, The EMBO journal.

[30]  S. Maurer-Stroh,et al.  Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  D. Qu,et al.  A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry , 2021, Nature Communications.

[32]  Vineet D. Menachery,et al.  Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.

[33]  M. Kiso,et al.  The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner , 2020, Viruses.

[34]  Neva C. Durand,et al.  A rapid, low-cost, and highly sensitive SARS-CoV-2 diagnostic based on whole-genome sequencing , 2020, bioRxiv.

[35]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[36]  S. Weiss,et al.  Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion , 2017, Journal of Virology.

[37]  Fang Li,et al.  Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.

[38]  J. Palmer,et al.  Bitter and sweet taste receptors regulate human upper respiratory innate immunity. , 2014, The Journal of clinical investigation.

[39]  G. Whittaker,et al.  Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein , 2012, Viruses.

[40]  S. Weiss,et al.  Endosomal Proteolysis by Cathepsins Is Necessary for Murine Coronavirus Mouse Hepatitis Virus Type 2 Spike-Mediated Entry , 2006, Journal of Virology.

[41]  T A Wyatt,et al.  All‐digital image capture and whole‐field analysis of ciliary beat frequency , 2003, Journal of microscopy.

[42]  Jing Liu,et al.  Human Nasal Epithelial Cells (hNECs ) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2. , 2022, Methods in molecular biology.